Luke Chen: VEXAS Syndrome – Uncovering Hidden Cases in Nova Scotia
Luke Chen, Hematologist at Dalhousie University, shared a post on LinkedIn about a recent article by Joey Fitzpatrick, published in QEII Foundation, adding:
“Thank you QEII Foundation for highlighting VEXAS in the latest issue of QEII Times.
The VEXAS (Vacuoles, E1 enzyme, X chromosome, autoinflammatory, somatic) syndrome was discovered in 2020 and typically appears in men over the age of 40 with protean manifestations such as relapsing polychondritis (ears and nose), cutaneous inflammation, high CRP, pulmonary disease, macrocytic cytopenias, vacuoles in bone marrow, and thrombosis, among other symptoms.
Often, high dose steroids are the only conventional treatment that controls the inflammation – but better therapies are available.
Statistically, there should be 75-80 cases in Nova Scotia … where are they?”
Title: QEII TIMES: Unlocking blood disease mysteries
Authors: Joey Fitzpatrick
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 8, 2026, 14:23Bianca Constantin: Science And Clinical Experience At The RSH National Conference
-
Oct 8, 2026, 14:17Sudhanshi Raina: Predicting Germline Mutations in Aplastic Anemia Using Telomere Length
-
Oct 8, 2026, 14:10Rebecca Akpeloo: PE as an Overlooked Threat in Sickle Cell Disease
-
Oct 8, 2026, 14:05Christina Pohlman: World Thrombosis Day – Raising Awareness of DVT
-
Oct 8, 2026, 13:59Patience Nkabe Odey: What Drives Rhesus D Screening Uptake Among Pregnant Women?
-
Oct 8, 2026, 13:50Todd Rice: ECMO at the Intersection of Anticoagulation and Respiratory Failure
-
Oct 8, 2026, 13:35Manuel Monreal: Why IVC Filter Retrieval Matters for VTE Outcomes
-
Oct 8, 2026, 12:53Hellen Ishikawa-Ankerhold: PhD and Postdoctoral Positions in Advanced Microscopy and Immunothrombosis at LMU Munich
-
Oct 8, 2026, 12:45Pedro Perez: World Thrombosis Day 2026 – Raising Awareness of Women’s VTE Risk